Answers are grounded in this paper and cite their sources.
The role that metabolic phenotyping can increasingly play in patient stratification and personalised medicine is discussed. The background to the general approach, comprehensive and simultaneous analysis of small-molecule metabolites in biofluids, tissues and tissue extracts combined with suitable multivariate statistical models, is summarised. The main techniques used (NMR and mass spectrometry) are cited, and the implementation of dedicated phenome centres is explained. Finally, the advantages and limitations, opportunities and drawbacks of the approach are discussed.
No takes yet. Share an insight, caveat, or question.
Lindon et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: